With more than 200 clinical trials in volving NK cells over the last decade, it is clear that these cells represent a prom ising tool in immunotherapy with a strong emphasis on cancer (Vivier et al., 2012) . Indeed, many studies in mice have highlighted the potential of NK cells to eradicate developing as well as established tumors of various origins. Their antitumor potential has also been highlighted in humans in the context of hematopoietic stem cell transplanta tion for acute myeloid leukemia. De spite the fact that genetic depletion models have only recently become available, and that cases of human NK cell deficiencies are rare, a large body of work has demonstrated that this innate immune cell population is also critical in the control of several viral, bacterial, and parasitic infections. Nevertheless, like many other immune cell types, NK cells can also be detrimental for the host and can contribute to the develop ment of immune disorders. The most compelling evidence of a "dark side" for NK cells comes from studies support ing a role for pancreasinfiltrating NK cells in the development of type1 diabetes (Feuerer et al., 2009) . To de velop successful NK cell-based thera pies, it is critical to clearly understand how their activity is regulated. New data adds to this understanding by show ing how regulatory T (T reg) cells and effector CD4 + T cells team up to con trol NK cell activation.
Ensuring appropriate activation NK cell activation relies on the inte gration of signals arising from activat ing and inhibitory receptors. Although key inhibitory receptors recognize class I MHC (MHCI) molecules, activating receptors recognize a range of ligands, including endogenous molecules re leased in situations of cellular stress, and viral proteins. This balance between in hibitory and activating signals allows NK cells to detect and kill stressed cells while sparing healthy ones. However, most inhibitory receptors are expressed in a stochastic fashion. As a consequence, the total NK cell population includes clones that will eventually express only inhibitory receptors that don't recognize endogenous MHCI, or even none of them, with the consequences of being potentially autoreactive by missingself recognition. So, like T and B cells, NK cells undergo an education process to ensure that only cells expressing inhibi tory receptors specific for endogenous MHCI, and thus selftolerant, will un dergo functional maturation. However, NK cell tuning relies not only on signals from inhibitory receptors but also on activating receptors such as NKG2D, Ly49H, or KIR2DS1, which induce NK cell hyporeactivity in the chronic pres ence of their ligands . Thus, NK cells such as T and B cells undergo an education process that adapts the threshold of NK cell reactivity to the host.
A second layer of regulation re volves around a process of functional priming controlled by the innate im mune system. Until recently, NK cells were thought to be poised and ready to kill target cells on contact. We now know, however, that resting NK cells from mice and humans are not hard wired and display relatively poor effec tor functions (e.g., cytotoxicity and cyto kine secretion) without an appropriate inflammatory context, such as den dritic cell (DC)-mediated IL15 trans presentation (Lucas et al., 2007; Ganal et al., 2012) . IL15 transpresentation results in the translation of perforin and Granzyme B mRNA pools in the NK cell (Fehniger et al., 2007) . Interestingly, it has been observed that mouse cyto megalovirus (MCMV) infection can lead to a breakdown in NK cell educa tion and tolerance to self, accompanied by a drastic increase in NK cell reactiv ity (Sun and Lanier, 2008) . mice with antiTGF antibodies did not recapitulate this phenotype, arguing against a predominant role for TGF. Instead, pancreatic NK cell activation was associated with increased expres sion of genes associated with IL2/Stat5 signaling. Additionally, the NK cell ac cumulation and IFN secretion that was induced upon T reg depletion could be prevented by treating the mice with IL2 antagonists. Treatment with IL2 agonists in the presence of T reg cells was sufficient to trigger the accumula tion of NK cells, IFN secretion, and diabetes. In parallel, in this issue Gasteiger et al. and Gasteiger et al. found that T reg cell depletion in Foxp3.DTR mice had no effect on NK cell selftolerance, ac tivation by cytokines, or expression of activating receptors. However, missing self-induced cytotoxicity was consis tently enhanced in a CD4 + T cell-and IL2-dependent way. As IL2 secretion by CD4 + T cells is greatly enhanced upon T reg cell depletion in Foxp3. DTR mice, and IL2 is largely confined to CD4 + T cells in the pancreas of BDC2.5/NOD mice, it is likely that T reg cell-dependent control of NK cell activity in vivo may require regu lation of IL2 production by activated T cells. Interestingly, IL2 deprivation is thought to be a prominent mecha nism used by T reg cells to suppress spontaneous T cell activation (Pandiyan et al., 2007; Josefowicz et al., 2012) . By limiting IL2 availability and thus controlling T cell activation, T reg cells can dynamically tune NK cell activity (Fig. 1) .
IL2 has long been used in vitro to stimulate NK cell proliferation and acti vation, leading to the generation of lymphokineactivated killer cells. Early IL2 secretion by activated CD4 + T cells is also required for NK cells to secrete IFN upon primary infection with Leishmania major in mice (Bihl et al., 2010) . In addition, the rapid secretion of IL2 by restimulated human memory T cells triggers NK cell activation, mim icking an antigenspecific memory NK cell response (Horowitz et al., 2010) . These results reinforce the importance of IL2 and the adaptive immune sys tem in the regulation of NK cell activity transplant rejection, whereas coinfusing donor T reg cells prevented it (Barao et al., 2006) . Finally, acute depletion of T reg cells in the BDC2.5/NOD mouse model of type 1 diabetes quickly lead to NK cell activation, IFN secretion, and dia betes progression (Feuerer et al., 2009) .
Collectively, these studies demon strate that T reg cells inhibit NK cell activity in vivo. In line with these find ings, in vitro experiments revealed that coculture of NK cells with T reg cells inhibited NK cell cytotoxicity against prototypic target cells in both mice and humans (Wolf et al., 2003; Smyth et al., 2006; Trzonkowski et al., 2004a; Ghiringhelli et al., 2005) , further sug gesting that T reg cells can directly act on NK cells. Initial in vitro studies revealed that this T reg cell-mediated inhibition was cell contact dependent and was not affected by formaldehyde fixation of the T reg cells (Ghiringhelli et al., 2005; Smyth et al., 2006) . This contact dependent inhibition was mediated in part by membranebound TGF, which is expressed on the surface of T reg cells, as blocking TGF abolished T reg cell-dependent NK cell inhibi tion (Ghiringhelli et al., 2005; Smyth et al., 2006; Barao et al., 2006; Sungur et al., 2013) . In addition, T reg cells de rived from TGF / mice were unable to inhibit NK cell functions (Ghiringhelli et al., 2005; . Depletion or func tional impairment of T reg cells in the mouse also leads to an accumulation of DCs expressing IL15R, which is as sociated with enhanced NK cell prolif eration (Terme et al., 2008) . T reg cells could therefore also indirectly control NK cells via DCs.
Effector T cells get in the mix
Three new studies now reveal a novel player in the interaction between T reg cells and NK cells. In this issue of the JEM, Sitrin et al. depleted T reg cells in the BDC2.5/NOD model of type 1 diabetes and found that NK cells up regulated genes involved in prolifera tion, cytokine secretion, and cytotoxicity. Loss of T reg cells also caused pancreatic NK cells to downregulate expression of genes involved in TGF signaling. How ever, treatment of T reg cell-sufficient NK cell-T reg cell cross-talk Recent studies have revealed a third layer of regulation that relies on the adaptive immune system, i.e., T reg cells and effector T cells. Foxp3expressing T reg cells are critical to the maintenance of adaptive immune tolerance. Mice (e.g., Scurfy) and humans (i.e., patients with immunodysregulation polyendocrinopa thy autoimmune enteropathy Xlinked) lacking T reg cells develop rapid, wide spread, aggressive, and ultimately lethal autoimmune disease ( Josefowicz et al., 2012) . In allogeneic transplantation set tings, T reg cells suppress graftversus host disease (Maury et al., 2010) . On the other hand, increased numbers of circu lating and tumorinfiltrating T reg cells have also been observed in many cancer types and correlate with poor prognosis, and depletion of T reg cells in mice improves tumor clearance (Shimizu et al., 1999) . Recent studies now show that the activity of T reg cells regulates that of NK cells. For example, the induction of NK cell effector function in response to the cKit tyrosine kinase inhibitor Gleevec (STI571) in patients with gas trointestinal stromal tumors, or in re sponse to exosomes in patients with melanoma, correlated with decreased T reg cell numbers, increased anti tumoral responses, and delayed cancer progression (Ghiringhelli et al., 2005 (Ghiringhelli et al., , 2006 . In patients undergoing HLA identical blood stem cell transplantation, increased donor T reg cell numbers were associated with reduced NK cell cytotoxic activity (Trzonkowski et al., 2004b) . Acute depletion of T reg cells in mice also lead to a significant increase in NK cell numbers, in line with the phe notype of Foxp3deficient Scurfy mice, which harbor abnormally activated and proliferating NK cells (Ghiringhelli et al., 2005; Kim et al., 2007) . In addi tion, whereas T reg cell transfer prevents the development of antitumoral NK cell-like activity, T reg cell (CD4 + CD25 + ) depletion enhances NK cell-dependent tumor suppression in transplantable tumor models in mice (Shimizu et al., 1999; Smyth et al., 2006) . Depletion of host T reg cells before allogeneic or hap loidentical bone marrow transplantation in mice also enhances NK cell-dependent depending on the inflammatory context, accounting for the adaptation of the NK cell response to various immune in sults and further preventing NK cell proliferation, accumulation and activation in the absence of an appropriate con comitant immune response.
The knowledge of this regulatory mechanism might be pharmacologically targeted to stimulate or dampen NK cell activity depending on the patho logical context. infection (Lee et al., 2012) . In other studies, Gasteiger et al. (2013a,b) ob served that CD25 is selectively expressed and upregulated on a subset of CD27 + immature NK cells upon T reg cell de pletion and in tumorbearing or chron ically infected mice, allowing for the IL2-dependent accumulation of these cells. Interestingly, they also found that lowdose IL12 enhances CD25 expres sion on CD127 + cells in vitro, whereas a combination of IL12 and IL18 up regulates CD25 on all NK cells (Lee et al., 2012) . IL18 was previously shown to be required for IFN secretion in duced by IL12 either alone or in com bination with IL2 (Chaix et al., 2008) . In light of these data, it appears that im mature CD127 + NK cells could bypass this IL18 requirement. As such, CD25 upregulation and IL2 responsiveness of NK cells seems to be finely regulated in vivo, both in homeostatic and infec tious conditions. It remained unclear, however, which population of NK cells was targeted by IL2. Indeed, resting NK cells express very low to no CD25, the specific  chain for the IL2 receptor, and require high IL2 concentrations to acquire cyto toxic function. Sitrin et al. (2013) found that CD25 + NK cells, which comprised a fairly small fraction of total pancreatic NK cells, were more potent IFN pro ducers than their CD25  counterparts upon T reg cell depletion in BDC2.5/ NOD mice. This suggests that the in vivo expression of CD25 is mandatory for IL2-dependent NK cell activation. It has been shown that CD25 expres sion is strongly, albeit transiently, up regulated by mouse NK cells in an IL12 and STAT4 dependent manner during the first few days of MCMV 
